Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses

US10682345B2 · kind B2 · utility

Inventors

• Balazs ALBRECHT · Sprendlingen, DE
• Michael Aven · Mainz, DE
• Janine LAMAR · Ingelheim am Rhein, DE

Key dates

• Filing date: May 8, 2019
• Grant date: Jun 16, 2020
• Expiry date: May 8, 2039

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61M2250/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The disclosure relates to the field of medicine, in particular to the field of veterinary medicine. The disclosure specifically relates to muscarinic antagonists (including long acting muscarinic antagonists (LAMAs)) for the treatment of airway disease, such as pulmonary disease, preferably recurrent airway obstruction (RAO), summer pasture associated obstructive pulmonary disease (SPAOPD), and inflammatory airway disease (IAD) in animals, preferably equines such as horses.